- Home
- CATX vs FTF Comparison
CATX vs FTF Comparison
Compare CATX & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- FTF
- Stock Information
- Founded
- CATX 1983
- FTF 2003
- Country
- CATX United States
- FTF United States
- Employees
- CATX N/A
- FTF N/A
- Industry
- CATX Medical/Dental Instruments
- FTF Finance/Investors Services
- Sector
- CATX Health Care
- FTF Finance
- Exchange
- CATX Nasdaq
- FTF Nasdaq
- Market Cap
- CATX 239.0M
- FTF 256.8M
- IPO Year
- CATX N/A
- FTF N/A
- Fundamental
- Price
- CATX $3.88
- FTF $6.40
- Analyst Decision
- CATX Strong Buy
- FTF
- Analyst Count
- CATX 11
- FTF 0
- Target Price
- CATX $12.90
- FTF N/A
- AVG Volume (30 Days)
- CATX 934.1K
- FTF 153.9K
- Earning Date
- CATX 08-13-2025
- FTF 01-01-0001
- Dividend Yield
- CATX N/A
- FTF 11.45%
- EPS Growth
- CATX N/A
- FTF N/A
- EPS
- CATX N/A
- FTF N/A
- Revenue
- CATX $1,471,000.00
- FTF N/A
- Revenue This Year
- CATX N/A
- FTF N/A
- Revenue Next Year
- CATX N/A
- FTF N/A
- P/E Ratio
- CATX N/A
- FTF N/A
- Revenue Growth
- CATX N/A
- FTF N/A
- 52 Week Low
- CATX $1.60
- FTF $5.76
- 52 Week High
- CATX $16.55
- FTF $6.56
- Technical
- Relative Strength Index (RSI)
- CATX 50.75
- FTF 47.89
- Support Level
- CATX $3.88
- FTF $6.32
- Resistance Level
- CATX $4.28
- FTF $6.41
- Average True Range (ATR)
- CATX 0.29
- FTF 0.05
- MACD
- CATX -0.06
- FTF -0.01
- Stochastic Oscillator
- CATX 14.61
- FTF 36.10
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.